A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3

The Effects of Anti-HIV Drugs in HIV-Infected Patients Who Do Not Have AIDS

NCT00001024 ·Status: COMPLETED ·Phase: NA

Treatment of AIDS and AIDS Related Complex. Part-1- Treatment of Patients With ARC (AZT Vs. Placebo)

NCT00002063 ·Status: COMPLETED ·Phase: NA

A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP

NCT00000700 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC

NCT00000999 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study to Evaluate the Efficacy of Zidovudine in Preventing CD4+ Lymphocyte Decline in Patients With Primary HIV Infection. (One Treatment Arm Receives Placebo)

NCT00000765 ·Status: COMPLETED ·Phase: NA

A Phase I/II Clinical Study of Nystatin I.V. (Intravenous) in Patients With HIV Infection.

NCT00002097 ·Status: COMPLETED ·Phase: PHASE1

A Study of CI-1012 in HIV-Infected Patients

NCT00002196 ·Status: COMPLETED ·Phase: PHASE1

The Effectiveness of Two Anti-HIV Treatments in HIV-Infected Patients

NCT00001057 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerance, Efficacy and Pharmacokinetics of Multiple Doses of sCD4-PE40 in the Treatment of HIV-Infected Individuals

NCT00002087 ·Status: COMPLETED ·Phase: PHASE1

Phase Ib/IIa Clinical Study of ACC017 Tablets

NCT06719310 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3

NCT00000625 ·Status: COMPLETED ·Phase: PHASE2

Small Trial of Alendronate Impact on the Reservoir of HIV

NCT07216794 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

NCT00084032 ·Status: WITHDRAWN ·Phase: NA

A Multicenter, Exploratory Study to Evaluate the Effects of Antiretroviral Cessation on Plasma Associated HIV-1 RNA

NCT00000840 ·Status: COMPLETED

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

NCT00000812 ·Status: COMPLETED ·Phase: PHASE1

Pyridostigmine as Immunomodulator in People Living With HIV

NCT03312244 ·Status: SUSPENDED ·Phase: PHASE2

Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy

NCT00367458 ·Status: COMPLETED ·Phase: PHASE2

MGD014 in HIV-Infected Individuals on Suppressive Antiretroviral Therapy

NCT03570918 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study Of PF-00232798 In HIV Positive Patients

NCT00495677 ·Status: COMPLETED ·Phase: PHASE2

A Multicenter Phase II Double-Blind Exploratory Study to Evaluate Differences Among Various Zidovudine/Didanosine Regimens on Quantitative Measures of Viral Burden in Relatively Early HIV-1 Infection

NCT00000823 ·Status: COMPLETED ·Phase: PHASE2

A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons

NCT00000743 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Concentration-Controlled Trial to Assess the Safety, Tolerance, Pharmacokinetics and Development of Decreased HIV-1 Susceptibility to the Combination of Atevirdine Mesylate (U-87201E), Zidovudine (AZT), and Didanosine (ddI)

NCT00000742 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Effectiveness of 524W91

NCT00002335 ·Status: COMPLETED ·Phase: PHASE1

Combination Therapy With 3BNC117 and 10-1074 in HIV-Infected Individuals

NCT03571204 ·Status: TERMINATED ·Phase: PHASE1

A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced Disease

NCT00002033 ·Status: COMPLETED ·Phase: NA